Chen Saisai

Southeast University, China

Title: MDK promotes M2 macrophage polarization to remodel the tumor microenvironment in clear cell renal cell carcinoma

---

Biography

Saisai Chen, PhD candidate in Surgery at Southeast University, is a prominent researcher from China specializing in cancer research. With a solid educational background that includes a Bachelor's degree in Clinical Medicine from Bengbu Medical College (2013-2018) and a Research-oriented Master's Degree in Surgery from Southeast University (2018-2021), Chen is currently pursuing his Doctor of Philosophy in Surgery at the same institution (2021-2025). His research focuses on the role of macrophages in cancer progression, particularly in prostate cancer. Chen has contributed significantly to the field, with notable publications such as "YY1 complex in M2 macrophage promotes prostate cancer progression by upregulating IL-6" in the Journal for Immunotherapy of Cancer (2023), and "ERR-activated GPR35 promotes immune infiltration level of macrophages in gastric cancer tissues" in Cell Death Discovery (2022). His work has been presented at major conferences, including the European Association of Urology Annual Congress (EAU 2022) and the Chinese Urological Association Annual Meeting (CUA 2022). Chen also leads a project funded by the National Natural Science Foundation of China and holds patents for innovative technologies, including a method for targeting M2 macrophages in prostate cancer and an enhancement method for endoscopic images. His research and contributions reflect a deep commitment to advancing cancer treatment and understanding tumor biology.

Abstract